1068 ATG-107, a Novel 2+1 CD3-based T Cell Engager (TCE) Targeting FLT3, Demonstrates Potent Preclinical Efficacy for the Treatment of AML
Regular and Young Investigator Award Abstracts(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Regular and Young Investigator Award Abstracts(2024)